
Republicans are planning to use the main component of the Supreme Court decision upholding President Barack Obama's health-care law—which characterized the individual mandate as a 'tax'—as a weapon to try to repeal it.
Subscriber Content Read Preview
Bristol-Myers Squibb's agreement to acquire diabetes-drug maker Amylin Pharmaceuticals for $5.3 billion gives Bristol more heft in a fast-growing market, but the New York-based pharmaceutical company still faces larger rivals with dominant products.
Subscriber Content Read Preview
Ann Romney's multiple sclerosis has taken her to one of the world's leading MS doctors, participation in a medical study at Harvard, and an unproven therapy called reflexology.
Subscriber Content Read Preview
GlaxoSmithKline kept up the pressure on Human Genome Sciences by extending its offer for the U.S. biotech company to July 20, four days after the target company's deadline for finding alternative suitors.
Subscriber Content Read Preview
Democrats and Republicans have found one more thing to disagree about: In the aftermath of the Supreme Court's health-care ruling, Democrats want to change the subject. Republicans don't.
Subscriber Content Read Preview
Connecticut officials believe some parents of college-aid children are taking advantage of the state's Medicaid health-insurance program for low-income adults.
A new front opened in efforts to reshape how the government implements Obama's health-care overhaul. Employers, insurers, hospitals, drug makers and others are angling for an advantage.
The Wall Street Journal tracked the stories of four people who stand at the health-care law's junctions of policy and performance and looked at what the high court's decision means for them.
Hospitals are urging states to expand Medicaid under the new health-care law, bringing a potent political force to bear on governors who face pressure from Republicans to opt out of the beefed-up program.
Subscriber Content Read Preview
Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.
Subscriber Content Read Preview
The Supreme Court's health-care ruling will hurt bottom lines at some companies in the sector, analysts say. But many note that a clearer picture of the industry's future is a benefit to all.
Two years of preparation by insurers, hospitals, drug makers and the rest of the health-care industry will now continue apace and possibly gain momentum.
The court upheld the mandate as a tax, in an opinion by Chief Justice John Roberts. The justices also found fault with part of the health-care law's expansion of Medicaid.
The Supreme Court's decision upholds the Obama administration's health-care law, but its future depends on which party controls the White House and Congress after elections in November.
Obama never wanted people to think of it as a tax. But the health-care overhaul, his signature domestic policy, survived because the high court ruled that the enforcement tool at its core is just that: a tax.
The Supreme Court's decision to let states opt out of the health overhaul's Medicaid expansion without losing current funding for the program lifts a budget mandate from states but could mean fewer Americans gain insurance coverage under the law.
Subscriber Content Read Preview
Purdue Pharma is trying to extend its exclusive rights to OxyContin, saying a new version it developed might substantially curtail abuse.
Subscriber Content Read Preview
The FDA approved weight-loss drug Belviq made by Arena Pharmaceuticals, the first obesity medicine to be approved in more than a decade.
Subscriber Content Read Preview
Small-business owners and CEOs are struggling to understand how one of the key elements of the health-care legislation affects their firms, according to a new survey by The Wall Street Journal and Vistage International.
The U.S. Supreme Court's decision upholding the health care law has major implications for job growth in the industry with IT health care jobs and those in primary care expected to grow.
Subscriber Content Read Preview
West Virginia sued 14 drug wholesalers to force stricter distribution of painkillers and other controlled substances, alleging the companies have benefited from the state's problem with prescription-drug abuse.
Like bees to honey, many makers of beauty products are including bee venom as an ingredient, touting its effect as a 'natural Botox.'
Subscriber Content Read Preview
Running logistics for cost-conscious health care and pharmaceutical companies is proving a lucrative and growing business for parcel shipping companies including UPS, FedEx and DHL.
The court's ruling preserves discounts consumers get on the Medicare drug plan doughnut hole. Drug makers worry Medicare might be able to lower prices it pays the companies even more.
Also: FDA panelists find little reason to recommend metal-on-metal hip replacements; the FDA approves a new drug for overactive bladder; and a report links the global war on drugs to the spread of HIV in some countries.
What does the federal health overhaul mean for insurance premiums? The short answer: It depends on who you are, where you are, and what kind of coverage you get.
The decision throws into question a key mechanism to millions more people into health coverage: the growth of Medicaid to include everyone making incomes up to 133% of the federal poverty level.
What's behind Bieber Fever? Neuroscience offers an explanation to why teens—girls in particular—become so passionate about some musicians.
Tay-Sachs disease is generally known as a Jewish genetic disorder. Now, researchers are beginning to focus on another community at risk: people of Irish descent.
Pharmacists can't actually prescribe drugs, but with their patients' permission they can call the physician to discuss recommended medications that may have been overlooked and ask whether the doctor wants to prescribe them.
For Missy Park, CEO of Title Nine sportswear company, providing employees with opportunities to work out is as important as hitting her sales numbers.
Device makers and some cardiologists are pressing for wider use of remote monitoring systems to catch potential defibrillator problems early.
These critical documents about your wishes for health care don't always work as planned. More flexibility might be the answer.
Health Matters: In developing countries—and even in many developed ones—many travelers over 50 face special concerns. Here's how to get ready.
An emerging focus on quality of life is helping health-care providers see the big picture—and makes for healthier, happier patients.
Boston cardiologist James Muller, who founded Infraredx, finds his quest to develop a test has been both long and elusive.
New treatments for chronic wounds have flooded the market. But a New York medical center may show that the most effective approach is preventing small problems from getting out of control in the first place.
The latest in medical education: simulations that offer hands-on training, the intense pressure of hospital work, and none of the risk
Journal articles on nation-wide flu vaccination in 1976:
Many young people today have now spent most of their lives on antidepressants. Have the drugs made them "emotionally illiterate"?
Matt Ridley on the benefits of our bacterial zoo.
Conservative or liberal, our moral instincts are shaped by evolution to strengthen 'us' against 'them.'
Subscriber Content Read Preview
Walt Mossberg reviews a new free service that creates a detailed physical and digital profile of your medical and personal information to be stored online in case of an emergency.
Get in-depth research on Health companies, including complete news and financials, earnings estimates and more.
Answers allows you to tap the knowledge of Community members. Answer a question below or ask a question.
The latest news and analysis delivered to your in-box. Check the boxes below to sign up.
Hello
Your question to the Journal Community Your comments on articles will show your real name and not a username.Why?
Create a Journal Community profile to avoid this message in the future. (As a member you agree to use your real name when participating in the Journal Community)